Literature DB >> 11934761

Management of co-infection with HIV and TB.

R Colebunders, M L Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11934761      PMCID： PMC1122753          DOI： 10.1136/bmj.324.7341.802

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.

Authors:  W J Burman; B E Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

2.  Trimethoprim-sulfamethoxazole prophylaxis in sub-Saharan Africa.

Authors:  X Anglaret
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

3.  Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

Authors:  J Murray; P Sonnenberg; S C Shearer; P Godfrey-Faussett
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

4.  Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.

Authors:  S Z Wiktor; M Sassan-Morokro; A D Grant; L Abouya; J M Karon; C Maurice; G Djomand; A Ackah; K Domoua; A Kadio; A Yapi; P Combe; O Tossou; T H Roels; E M Lackritz; D Coulibaly; K M De Cock; I M Coulibaly; A E Greenberg
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

5.  Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.

Authors:  M A Quigley; A Mwinga; M Hosp; I Lisse; D Fuchs; P Godfrey-Faussett
Journal:  AIDS       Date:  2001-01-26       Impact factor: 4.177

Review 6.  A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes.

Authors:  W M El-Sadr; D C Perlman; E Denning; J P Matts; D L Cohn
Journal:  Clin Infect Dis       Date:  2001-02-09       Impact factor: 9.079

7.  Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.

Authors:  D W Fitzgerald; M Desvarieux; P Severe; P Joseph; W D Johnson; J W Pape
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

8.  Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.

Authors:  T Aisu; M C Raviglione; E van Praag; P Eriki; J P Narain; L Barugahare; G Tembo; D McFarland; F A Engwau
Journal:  AIDS       Date:  1995-03       Impact factor: 4.177

9.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321
  9 in total
  2 in total

1.  Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus.

Authors:  Lei Pan; Zhan-Sheng Jia; Lin Chen; En-Qing Fu; Guang-Yu Li
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

2.  Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatients at a Community Care Center.

Authors:  Nirmala Rajagopalan; Joyce B Suchitra; Anita Shet; Zafar K Khan; Julio Martin-Garcia; Michael R Nonnemacher; Jeffrey M Jacobson; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.